Lanean...
Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with a grim overall 5-year survival rate of 5%. Advances in surgical techniques, critical care, molecular diagnosis, diagnostic imaging, endosonology and adjuvant therapy have improved outcomes; but still more needs to be...
Gorde:
| Argitaratua izan da: | World J Gastrointest Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309949/ https://ncbi.nlm.nih.gov/pubmed/25685272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v7.i2.6 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|